previous compound ID: 865 next compound
InChIKey: HOMGKSMUEGBAAB-UHFFFAOYSA-N
SMILES: C1CN(P(=O)(OC1)NCCCl)CCCl

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"B Kus" "DY Thomas" "J Liao" "GW Carlile" "SD Macknight" "D Rotin" "E Matthes" "JW Hanrahan" "R Robert" "J Goepp"

chemical graph of compound 865





CID is 3690
synonyms found at PubChem are:
ifosfamide, Isophosphamide, 3778-73-2, Iphosphamide, Isofosfamide, Ifosfamid, Mitoxana, Naxamide, Iphosphamid, Isoendoxan, Ifex, I-Phosphamide, Holoxan, Cyfos, Ifsofamide, Holoxan 1000, ASTA Z 4942, Ifosfamida, Ifosfamidum, Ifosphamide, MJF 9325, (D,L)-Ifosfamide, isosfamide, (+-)-Ifosfamid, (+-)-Ifosphamide, (R,S)-Ifosphamide, NCI-C01638, Iso-Endoxan, MJF-9325, Ifosfamide Sterile, Ifosfamidum [INN-Latin], Ifosfamida [INN-Spanish], 2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide, NSC 109724, NSC-109724, A 4942, Z 4942, Z-4942, Iphosphamid(e), Z4942, CCRIS 352, N,3-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide, HSDB 7023, Ifosfamide [USAN:INN:BAN:JAN], N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid diamide, 3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide, EINECS 223-237-3, NSC109724, IFEX (TN), NPFAPI-04, BRN 0611835, dexifosfamide, C7H15Cl2N2O2P, Ifosfamide (JAN/USP/INN), N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide, CHEBI:5864, HOMGKSMUEGBAAB-UHFFFAOYSA-N, 2,3-(N,N(sup 1)-Bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxyd, N,N-Bis(beta-chloroethyl)-amino-N',O-propylene-phosphoric acid ester diamide, N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide, (+-)-Tetrahydro-N,3-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide, (R,S)-N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide, 1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide, 3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorine oxide, 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorineoxide, N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid [German], N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylene phosphoric acid ester diamide, NCGC00016639-01, CAS-3778-73-2, DSSTox_CID_760, N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid, 2H-1,3,2-Oxazaphosphorin-2-amine, tetrahydro-N,3-bis(2-chloroethyl)-, 2-oxide, (+-)-, 2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide, 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide, DSSTox_RID_75775, DSSTox_GSID_20760, Q-101874, Iso Endoxan, N,3-bis(2-chloroethyl)-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)-1,3,2-oxazaphosphinane 2-oxide, N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylen ephosphoric acid diamide, 1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide, 2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide, N-(2-Chloroethyl)-N-(3-(2-chloroethyl)-2-oxido-1,3,2-oxazaphosphinan-2-yl)amine, 2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide (8CI), 84711-20-6, SR-05000002022, ifomide, ifosfomide, Mitoxana;Ifex, N,3-bis(2-chloroethyl)-2-oxo-1,3,2?^{5}-oxazaphosphinan-2-amine, Ifosfamid A, (R)-Ifosfamide, (S)-Ifosfamide, 3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorineoxide, 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorine oxide, Mitoxana (TN), Isophosphamide,(S), Ifosfamide [USAN:USP:INN:BAN:JAN], NSC-109,724, Ifosfamide, >=98%, AC1L1GHW, Prestwick0_000833, Prestwick1_000833, Prestwick2_000833, Prestwick3_000833, D02TLO, Mitoxana, Ifex, Ifosfamide, SCHEMBL4885, CHEMBL1024, BSPBio_000785, KSC948G4P, MLS002154021, 3,} 2-oxazaphosphorine oxide, Ifex (TN) (Bristol Meyers), SPBio_002706, BPBio1_000865, GTPL7201, DTXSID7020760, CTK8E8347, KS-00000YBW, MolPort-003-666-704, BDBM189358, HMS1570H07, HMS2090M12, HMS2093N07, HMS2097H07, HMS2232O10, HMS3374B08, HMS3654B15, HMS3714H07, Pharmakon1600-01505480, {3-(2-Chloroethyl)-2-[(2-, BCP06596, WLN: T6NPOTJ AM2G BO B2G, Tox21_110539, Tox21_201815, Tox21_302775, BBL028071, CI0037, NSC759154, s1302, STL058690, AKOS005711213, Tox21_110539_1, AB02316, AC-2113, AN-6958, API0002976, CCG-213464, CS-1424, DB01181, MCULE-1480299331, NSC-759154, Ifosfamide, analytical reference material, NCGC00179435-01, NCGC00179435-02, NCGC00179435-03, NCGC00179435-06, NCGC00179435-07, NCGC00256413-01, NCGC00259364-01, AS-10978, CC-29468, HY-17419, LS-99799, NCI60_000233, SC-12120, SMR001233348, TA-01010, ACM1189701130, SBI-0206804.P001, AB0008491, AB2000039, KB-333868, AB00513932, FT-0603650, C07047, D00343, J10093, M-1494, 33899-EP2275420A1, 33899-EP2295055A2, 33899-EP2295416A2, 33899-EP2298748A2, 33899-EP2298764A1, 33899-EP2298765A1, 33899-EP2305642A2, 33899-EP2311453A1, AB00513932-06, AB00513932-07, AB00513932-08, AB00513932_09, AB00513932_10, 778I732, C-16296, I06-0494, SR-05000002022-1, SR-05000002022-3, SR-05000002022-5, BRD-A67097164-001-11-2, Ifosfamide, British Pharmacopoeia (BP) Reference Standard, Ifosfamide, European Pharmacopoeia (EP) Reference Standard, UNII-UM20QQM95Y component HOMGKSMUEGBAAB-AWEZNQCLSA-N, Ifosfamide, United States Pharmacopeia (USP) Reference Standard, 2,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxy-, 2,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd, 2,3-N,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxy-, 2,3-N,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd, N,3-bis(2-chloroethyl)-2-oxo-1,3,2$l;{5}-oxazaphosphinan-2-amine, (2S)-3-(2-chloroethyl)-2-[(2-chloroethyl)amino]-1,3,2|E5-oxazaphosphinan-2-one, {3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,} 2-oxazaphosphorine oxide, 1,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide, 2H-1,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide, 2H-1,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide, 2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis( 2-chloroethyl)tetrahydro-, 2-oxide, 3-(2-Chloroethyl)-2-(2-chloroethylamino)tetrahydro-2H-1,3,2-oxazaphosphorin-2-one, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]-1,3,2$l;{5}-oxazaphosphinan-2-one, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]-1,3,2lambda5-oxazaphosphinan-2-one, 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,2-oxazaphosphorine oxide, 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,2-oxazaphosphorineoxide, 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,2-oxazaphosphorine 2-oxide, 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2- oxide, N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphinan-2-amine 2-oxide #, 36341-88-5